Skip to main content
Clinical Trials/NCT01899911
NCT01899911
Completed
Not Applicable

Pulse Oximeter Response TO Multiple Levels Of Stable Hypoxia

LifeWatch Services, Inc.1 site in 1 country12 target enrollmentMarch 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Desaturation of Blood
Sponsor
LifeWatch Services, Inc.
Enrollment
12
Locations
1
Primary Endpoint
Composite Outcome Measure: Successful Capture of Peripheral Capillary Oxygen Saturation (SpO2) Level
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

A clinical study designed to determine the accuracy of the peripheral capillary oxygen saturation (SpO2) function of the Vital Signs Patch (VSP) device for measuring blood saturation level.

Detailed Description

The clinical study protocol was designed for determining the accuracy of the SpO2 function of the Vital Signs Patch device for measuring blood oxygen saturation level, according to the guidelines for "evaluating and documenting SpO2 accuracy in human subjects" as set out in Annex EE of ISO 80601-2-61. Section 4.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
March 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Ages 23 to
  • Skin tone varied from light to dark.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Composite Outcome Measure: Successful Capture of Peripheral Capillary Oxygen Saturation (SpO2) Level

Time Frame: within 24 hrs

Successful capture of SpO2 levels - Infrared and red light absorbency was measured and used for SpO2 percentage calculation from both the Vital Signs Patch (VSP) study device and an invasive Blood Arterial Hemoximeter (standard method) to determine the level of accuracy of data obtained from the VSP device when compared data taken from the Arterial Hemoximeter. A comparison was made by calculating the Average Root Mean Square (Arms) and comparing against the Arms error rate limit of less than or equal to 3.5% at a 95% confidence level. The outcome is either positive or negative - this is a composite outcome measure.

Study Sites (1)

Loading locations...

Similar Trials